Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Analgesia seen with NP-2 in phase I study

Nov. 14, 2011

Pharmacokinetics and safety of E-7050 assessed in humans

Nov. 14, 2011

PRT-201 shows promise in patients with kidney disease on hemodialysis

Nov. 14, 2011

Novel clinical data and analyses presented on Regeneron's rilonacept

Nov. 14, 2011

Tocilizumab assessed in large vessel vasculitis

Nov. 14, 2011

LB-80380 compared to entecavir in phase IIb trial

Nov. 14, 2011

Hepatitis C virus resistance characterized in multiple-dose trial of GS-5885

Nov. 14, 2011

First-in-human data released on candidate hepatitis C therapy

Nov. 14, 2011

Data reported on immunotherapy for use in liver transplantation for chronic hepatitis C

Nov. 11, 2011

Analyses highlight importance of patient selection for diabetic nephropathy therapy

Nov. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...